Can J Psychiatry

1. KORANN V, Panganiban KJ, Stogios N, Remington G, et al
   The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics: La deregulation du systeme glymphatique en presence de troubles psychotiques chez des patients peu exposes a des antipsychoti
   Can J Psychiatry. 2024 Oct 21:7067437241290193. doi: 10.1177/07067437241290193.
   

   >> Share

   
   

   
   Clin Pharmacokinet

2. SZABO M, Hujber Z, Harsanyi J, Szatmari B, et al
   Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring.
   Clin Pharmacokinet. 2024 Oct 20. doi: 10.1007/s40262-024-01431.
   

   >> Share

   
   

   
   Psychiatry Res

3. CIOFFI L, Wein PY, Miller SA, Fagan S, et al
   Clinical, neurocognitive, neurobiological and functional correlates of sleep difficulties in individuals at-risk for psychosis and mania: A scoping review.
   Psychiatry Res. 2024;342:116235.
   

   >> Share

   
   
4. DUDLEY R, White S, Miskin R, Oakes L, et al
   Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis.
   Psychiatry Res. 2024;342:116229.
   

   >> Share

   
   

   
   Schizophr Res

5. SABBAH SG, Northoff G
   Basic self-disturbance in schizophrenia: From neuronal to mental topographic dedifferentiation.
   Schizophr Res. 2024;274:327-328.
   

   >> Share

   
   
6. ULIANA DL, Martinez A, Grace AA
   THPP-1 PDE10A inhibitor reverses the cognitive deficits and hyperdopaminergic state in a neurodevelopment model of schizophrenia.
   Schizophr Res. 2024;274:315-326.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share